Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10 PM ET David Altshuler - Executive Vice President, Global Research and CSO ...
The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 for the treatment of acute pain. LTG-001, an oral Nav1.8 selective ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
A scientific statement regarding pain and treatment considerations in patients with PAD has been published by the AHA.
Ditch the painkillers! While they can provide temporary relief, there are other ways to numb pain without medication. Find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results